Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2024 | Comparing transplantation outcomes: haploidentical vs. unrelated donors

Raynier Devillier • 15 Apr 2024
EBMT 2024
General

Raynier Devillier, MD, PhD, Paoli-Calmettes Institute, Marseille, France, discusses transplantation outcomes for patients who have a haploidentical versus unrelated donor. Data from the SFGM-TC (The French Society of Marrow Transplantation and Cellular Therapy) supports that survival outcomes are similar between the two donor types, allowing physicians to choose between the two based on individual patient needs. Dr Devillier also mentions the importance of individualizing conditioning regimens and graft-versus-host disease (GvHD) prophylaxis. This interview took place at the 50th Annual Meeting of the EBMT in Glasgow, Scotland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Raynier Devillier

2:22
Haplo-SCT for older patients with AML/HR-MDS: should age be a barrier to transplantation?
Raynier Devillier • 15 Apr 2024

Related Videos

2:15
Cardiac biomarkers for immune checkpoint inhibitor-related myocarditis in cancer patients
Arjun Ghosh • 25 Apr 2024
1:09
Rethinking healthcare to improve affordability, sustainability, and patient outcomes
Richard Sullivan • 29 Apr 2024
3:10
The importance of nutrition in hematology and cancer care
Shireen Kassam • 24 Apr 2024
2:41
A trial investigating enoxaparin vs placebo as thromboprophylaxis in hospitalized older patients
Gregoire Le Gal • 29 Apr 2024
The content of VJHemOnc is intended for healthcare professionals